Gatehouse Bio

Huge Congratulations to the 2024 Nobel Prize Winners in Physiology or Medicine! https://lnkd.in/eV4JGNEj We at Gatehouse Bio are thrilled to see Victor Ambros and Gary Ruvkun receive the Nobel Prize in Physiology or Medicine for their groundbreaking discovery of microRNA (miRNA) and its pivotal role in post-transcriptional gene regulation. This achievement is a testament to the significance of miRNA in controlling gene expression, a fundamental process in biology that has far-reaching implications for human health and disease. Building on their pioneering work At Gatehouse Bio, we're honored to be building upon the discoveries of Ambros and Ruvkun by expanding our understanding of how isoforms of miRNA and other small RNA play a role in driving complex diseases. Our research is focused on uncovering the intricate mechanisms by which these molecules regulate gene expression and contribute to the development of diseases. Unlocking the secrets of isoform biology We believe that the key to unlocking new therapeutic opportunities lies in understanding the specific roles of miRNA isoforms and other small RNA molecules in disease biology. By exploring the complex interactions between these molecules and their targets, we aim to develop innovative treatments that can address the root causes of disease. The impact of miRNA on human health The discovery of miRNA has revolutionized our understanding of gene regulation and its implications for various biological processes and diseases. miRNAs have been implicated in numerous physiological and pathological processes, including development, cell differentiation, and disease states such as cancer. This knowledge has opened up new avenues for research into the mechanisms of disease and the development of novel therapeutic strategies. We're proud to be part of the miRNA community We'd like to extend our warmest congratulations to Victor Ambros and Gary Ruvkun on this well-deserved recognition. Their work has inspired a generation of scientists and researchers, and we're proud to be part of the community that's building on their discoveries. We look forward to continuing to advance the field of miRNA research and exploring its vast potential for improving human health. Join us in celebrating this achievement! Let's come together to recognize the significance of this Nobel Prize award and the impact it will have on the future of medicine and biotechnology. Share your thoughts and congratulations in the comments below! #NobelPrize #miRNA #GeneRegulation #GatehouseBio #Innovation #Biotechnology #Medicine #IsoformBiology #SmallRNA #ComplexDiseases 

AnaBios is pleased to announce that Dr. David W. Salzman, Gatehouse Bio Chief Executive Officer, is the winner of the 2024 Translational Research Grant Award. Dr. Salzman will obtain up to $15,000 in AnaBios’ high-quality precision-cut lung slices to help Gatehouse Bio advance #drugdevelopment in idiopathic pulmonary #fibrosis. Click the link below to read the full announcement. #earlyhumaninsights #translationalresearch

The long awaited webinar is here today. Come join us to here Dr David. Salzman share the latest in small non coding RNA biology!

Want to explore the next frontier of precision medicine? Our Managing Partner Erica Sosnowski will be moderating a live webinar featuring Dr. David W. Salzman, Founder & CEO of Gatehouse Bio, to learn the vast impacts of small RNA (sRNA) on the future of #precisionmedicine and other therapies. Live Webinar: Leveraging Small RNA Isoforms for Precision Medicine When: Tuesday, March 26, 2024 @ 10:00 AM - 11:00 AM EDT REGISTER NOW: https://buff.ly/3IsvXg4 #smallrna #srna #microRNA #rnamedicine #oligonucleotide #oligo